3541 LogoPNG

InsightAce Analytic Pvt. Ltd. is pleased to announce the publication of a market analysis research on “Global Immuno-oncology cell therapy market trends, industry competition analysis, revenue and forecast to 2030.”

Request for Sample Pages: https://www.insightaceanalytic.com/report/global-immuno-oncology-cell-therapy-market/1083

immuno-oncology cell therapy market

Immuno-oncology cell therapy is one of the fastest advancing technologies, along with massive research and development activities. Immuno-oncology is a biological treatment that boosts the body’s immune system to stop cancer growth. The oncology market today could be quickly superseded by next-generation therapies in the upcoming forecast period.

The fast adoption of cancer immunotherapies over other conventional cancer treatments, development of bioinformatics tools, high prevalence of cancer worldwide, increased demand for personalized medicine, increasing R&D investments for immuno-oncology therapy development are the major driving factors of the global immuno-oncology cell therapy market. Furthermore, the use of various bioinformatics tools reduces the cost and time of the drug development process, enabling pharmaceutical companies to monitor and evaluate their products more efficiently and rapidly.  Thus, bioinformatics and different software tools increase the interest of researchers to innovate novel cancer therapies, thereby increasing the adoption of the cancer immunotherapy market.  

However, the high cost of immuno-oncology therapies, stringent regulatory requirements for biomarkers, and poor reimbursement policies are expected to hamper the growth of market during the forecast period.

Geographically, the Asia Pacific region is expected to witness the fastest growth during the forecast period (2021-2030) due to the high prevalence of cancer, increasing use of bioinformatics tools & data for drug designing, and rising government funding for the healthcare sector. Especially, China, India, and Japan are the major countries in this market.

Request for ToC/Proposal: https://www.insightaceanalytic.com/report/global-immuno-oncology-cell-therapy-market/1083

Major market players operating in the immuno-oncology cell therapy market include Novartis (Switzerland), Juno Therapeutics (US), Agios Pharmaceutical (US), Atara Biotherapeutics (US), China Immunotech Co., Ltd. (China), Autolus Limited (UK), Kite Pharma (US), Bellicum Pharmaceuticals (US), bluebird bio (US), Calibr (US), Carina Biotech (Australia), CARsgen Therapeutics (China), Celgene Corporation (US), Cellectis (France), Editas Medicine (US), Allogene Therapeutics (US), Amgen (US) among others.

Recent key developments in the market are as follows: https://www.insightaceanalytic.com/report/global-immuno-oncology-cell-therapy-market/1083

  • In January 2021, Novartis (Switzerland) collaborated with BeiGene, Ltd. to in-license tislelizumab from BeiGene, Ltd. in major markets outside of China. This agreement is expected to accelerate the potential for Novartis to enter the large and growing checkpoint inhibitor field. Tislelizumab is an anti-PD-1 monoclonal antibody specifically designed to minimize binding to FcγR on macrophages.
  • In January 2018, Celgene Corporation (US) acquired Juno Therapeutics, Inc. (US), a company engaged in the development of CAR (chimeric antigen receptor) T and TCR (T cell receptor) therapeutics. This acquisition added a novel scientific platform and scalable manufacturing capabilities to complement Celgene’s hematology and oncology leadership.

Curious about this most recent version of the report?  Obtain Report Details @ https://www.insightaceanalytic.com/report/global-immuno-oncology-cell-therapy-market/1083

Market Segments

Global Immuno-Oncology Cell Therapy Market, by Therapy Type, 2020-2030 (Value US$ Mn)

  • CAR-T Cells
  • NK & NKT Cells
  • TAA/TSA targeted T Cell
  • TCR T Cell
  • Cytokine-induced killer cells
  • Dendritic cells
  • Macrophages
  • Other Cell Therapies

Global Immuno-Oncology Cell Therapy Market, by Major Indications, 2020-2030 (Value US$ Mn)

  • Head & Neck Cancer
  • Lung Cancer
  • Kidney Cancer
  • Melanoma
  • Lymphoma
  • Leukemia
  • others

Global Immuno-Oncology Cell Therapy Market, by Region, 2020-2030 (Value US$ Mn)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

North America Immuno-Oncology Cell Therapy Market, by Country, 2020-2030 (Value US$ Mn)

  • U.S.
  • Canada

Europe Immuno-Oncology Cell Therapy Market, by Country, 2020-2030 (Value US$ Mn)

  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

Asia Pacific Immuno-Oncology Cell Therapy Market, by Country, 2020-2030 (Value US$ Mn)

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America Immuno-Oncology Cell Therapy Market, by Country, 2020-2030 (Value US$ Mn)

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa Immuno-Oncology Cell Therapy Market, by Country, 2020-2030 (Value US$ Mn)

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Why should buy this report:

  • To receive a comprehensive analysis and key insights of the prospects for the global immuno-oncology cell therapy market
  • To receive an industry overview and upcoming industry trends in the immuno-oncology cell therapy market
  • To analyze the immuno-oncology cell therapy market drivers and challenges
  • To get information on the immuno-oncology cell therapy market value (US$ Mn) and forecast to 2030
  • Significant investments, mergers & acquisitions in the immuno-oncology cell therapy market industry

For More Information @ https://www.insightaceanalytic.com/report/global-immuno-oncology-cell-therapy-market/1083

Tags: immuno oncology cell therapy market, insightace analytic pvt ltd, Immuno-Oncology, market research report

See Campaign: https://www.insightaceanalytic.com/
Contact Information:
Tel.: + +1 551 226 6109 Email: info@insightaceanalytic.com

Tags:
Reportedtimes, iCN Internal Distribution, Research Newswire, English